WAYSTAR HOLDING CORP (WAY) Fundamental Analysis & Valuation
NASDAQ:WAY • US9467841055
Current stock price
24.36 USD
-0.42 (-1.69%)
Last:
This WAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. WAY Profitability Analysis
1.1 Basic Checks
- In the past year WAY was profitable.
- WAY had a positive operating cash flow in the past year.
- In the past 5 years WAY reported 4 times negative net income.
- Each year in the past 5 years WAY had a positive operating cash flow.
1.2 Ratios
- With a decent Return On Assets value of 1.94%, WAY is doing good in the industry, outperforming 74.29% of the companies in the same industry.
- WAY's Return On Equity of 2.89% is fine compared to the rest of the industry. WAY outperforms 71.43% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 2.93%, WAY is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
- WAY had an Average Return On Invested Capital over the past 3 years of 2.33%. This is significantly below the industry average of 7.42%.
- The last Return On Invested Capital (2.93%) for WAY is above the 3 year average (2.33%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.94% | ||
| ROE | 2.89% | ||
| ROIC | 2.93% |
ROA(3y)0.13%
ROA(5y)-0.34%
ROE(3y)-0.08%
ROE(5y)-0.98%
ROIC(3y)2.33%
ROIC(5y)1.82%
1.3 Margins
- WAY has a better Profit Margin (10.20%) than 94.29% of its industry peers.
- The Operating Margin of WAY (22.75%) is better than 94.29% of its industry peers.
- In the last couple of years the Operating Margin of WAY has grown nicely.
- WAY has a better Gross Margin (68.33%) than 68.57% of its industry peers.
- In the last couple of years the Gross Margin of WAY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.75% | ||
| PM (TTM) | 10.2% | ||
| GM | 68.33% |
OM growth 3Y23.51%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.57%
GM growth 5YN/A
2. WAY Health Analysis
2.1 Basic Checks
- WAY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, WAY has more shares outstanding
- WAY has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 1.82 indicates that WAY is not a great score, but indicates only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 1.82, WAY is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
- WAY has a debt to FCF ratio of 5.20. This is a neutral value as WAY would need 5.20 years to pay back of all of its debts.
- WAY's Debt to FCF ratio of 5.20 is fine compared to the rest of the industry. WAY outperforms 62.86% of its industry peers.
- WAY has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of WAY (0.38) is worse than 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 5.2 | ||
| Altman-Z | 1.82 |
ROIC/WACC0.33
WACC8.94%
2.3 Liquidity
- WAY has a Current Ratio of 1.41. This is a normal value and indicates that WAY is financially healthy and should not expect problems in meeting its short term obligations.
- WAY has a Current ratio of 1.41. This is in the lower half of the industry: WAY underperforms 62.86% of its industry peers.
- A Quick Ratio of 1.41 indicates that WAY should not have too much problems paying its short term obligations.
- WAY has a worse Quick ratio (1.41) than 62.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 |
3. WAY Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 477.78% over the past year.
- The Revenue has grown by 16.50% in the past year. This is quite good.
- Measured over the past years, WAY shows a quite strong growth in Revenue. The Revenue has been growing by 15.97% on average per year.
EPS 1Y (TTM)477.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.14%
Revenue 1Y (TTM)16.5%
Revenue growth 3Y15.97%
Revenue growth 5YN/A
Sales Q2Q%24.35%
3.2 Future
- The Earnings Per Share is expected to grow by 13.80% on average over the next years. This is quite good.
- Based on estimates for the next years, WAY will show a quite strong growth in Revenue. The Revenue will grow by 11.16% on average per year.
EPS Next Y17.16%
EPS Next 2Y15.29%
EPS Next 3Y15.69%
EPS Next 5Y13.8%
Revenue Next Year18.17%
Revenue Next 2Y14.28%
Revenue Next 3Y13.5%
Revenue Next 5Y11.16%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. WAY Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 17.28, WAY is valued on the expensive side.
- Compared to the rest of the industry, the Price/Earnings ratio of WAY indicates a somewhat cheap valuation: WAY is cheaper than 80.00% of the companies listed in the same industry.
- WAY's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.73.
- The Price/Forward Earnings ratio is 14.75, which indicates a correct valuation of WAY.
- Based on the Price/Forward Earnings ratio, WAY is valued a bit cheaper than 77.14% of the companies in the same industry.
- WAY is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.72, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.28 | ||
| Fwd PE | 14.75 |
4.2 Price Multiples
- WAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. WAY is cheaper than 62.86% of the companies in the same industry.
- 74.29% of the companies in the same industry are more expensive than WAY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.49 | ||
| EV/EBITDA | 15.64 |
4.3 Compensation for Growth
- WAY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of WAY may justify a higher PE ratio.
- A more expensive valuation may be justified as WAY's earnings are expected to grow with 15.69% in the coming years.
PEG (NY)1.01
PEG (5Y)N/A
EPS Next 2Y15.29%
EPS Next 3Y15.69%
5. WAY Dividend Analysis
5.1 Amount
- No dividends for WAY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
WAY Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:WAY (3/20/2026, 11:49:07 AM)
24.36
-0.42 (-1.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-17 2026-02-17/bmo
Earnings (Next)04-28 2026-04-28
Inst Owners82.3%
Inst Owner Change6.04%
Ins Owners1.85%
Ins Owner Change2.65%
Market Cap4.67B
Revenue(TTM)1.10B
Net Income(TTM)112.09M
Analysts85.19
Price Target37.5 (53.94%)
Short Float %8.46%
Short Ratio4.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.56%
Min EPS beat(2)-9.5%
Max EPS beat(2)4.39%
EPS beat(4)2
Avg EPS beat(4)-0.02%
Min EPS beat(4)-9.5%
Max EPS beat(4)6.31%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.92%
Min Revenue beat(2)2.25%
Max Revenue beat(2)3.6%
Revenue beat(4)4
Avg Revenue beat(4)3.04%
Min Revenue beat(4)2.25%
Max Revenue beat(4)3.95%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-21.3%
PT rev (3m)-24.98%
EPS NQ rev (1m)0.78%
EPS NQ rev (3m)0.07%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.36%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)0.78%
Revenue NY rev (1m)0.39%
Revenue NY rev (3m)1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.28 | ||
| Fwd PE | 14.75 | ||
| P/S | 4.25 | ||
| P/FCF | 16.49 | ||
| P/OCF | 15.08 | ||
| P/B | 1.2 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.64 |
EPS(TTM)1.41
EY5.79%
EPS(NY)1.65
Fwd EY6.78%
FCF(TTM)1.48
FCFY6.06%
OCF(TTM)1.62
OCFY6.63%
SpS5.73
BVpS20.24
TBVpS-7.46
PEG (NY)1.01
PEG (5Y)N/A
Graham Number25.34
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.94% | ||
| ROE | 2.89% | ||
| ROCE | 4.49% | ||
| ROIC | 2.93% | ||
| ROICexc | 2.98% | ||
| ROICexgc | 95.36% | ||
| OM | 22.75% | ||
| PM (TTM) | 10.2% | ||
| GM | 68.33% | ||
| FCFM | 25.76% |
ROA(3y)0.13%
ROA(5y)-0.34%
ROE(3y)-0.08%
ROE(5y)-0.98%
ROIC(3y)2.33%
ROIC(5y)1.82%
ROICexc(3y)2.38%
ROICexc(5y)1.85%
ROICexgc(3y)62.49%
ROICexgc(5y)50.41%
ROCE(3y)3.57%
ROCE(5y)2.79%
ROICexgc growth 3Y48.7%
ROICexgc growth 5YN/A
ROICexc growth 3Y34.39%
ROICexc growth 5YN/A
OM growth 3Y23.51%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.57%
GM growth 5YN/A
F-Score6
Asset Turnover0.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 5.2 | ||
| Debt/EBITDA | 3.73 | ||
| Cap/Depr | 18.84% | ||
| Cap/Sales | 2.41% | ||
| Interest Coverage | 3.06 | ||
| Cash Conversion | 79.27% | ||
| Profit Quality | 252.65% | ||
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z | 1.82 |
F-Score6
WACC8.94%
ROIC/WACC0.33
Cap/Depr(3y)15.22%
Cap/Depr(5y)12.68%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)477.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%24.14%
EPS Next Y17.16%
EPS Next 2Y15.29%
EPS Next 3Y15.69%
EPS Next 5Y13.8%
Revenue 1Y (TTM)16.5%
Revenue growth 3Y15.97%
Revenue growth 5YN/A
Sales Q2Q%24.35%
Revenue Next Year18.17%
Revenue Next 2Y14.28%
Revenue Next 3Y13.5%
Revenue Next 5Y11.16%
EBIT growth 1Y102.15%
EBIT growth 3Y43.22%
EBIT growth 5YN/A
EBIT Next Year58.23%
EBIT Next 3Y26.58%
EBIT Next 5Y18.67%
FCF growth 1Y98.73%
FCF growth 3Y49.24%
FCF growth 5YN/A
OCF growth 1Y82.41%
OCF growth 3Y44.5%
OCF growth 5YN/A
WAYSTAR HOLDING CORP / WAY Fundamental Analysis FAQ
What is the fundamental rating for WAY stock?
ChartMill assigns a fundamental rating of 5 / 10 to WAY.
What is the valuation status of WAYSTAR HOLDING CORP (WAY) stock?
ChartMill assigns a valuation rating of 5 / 10 to WAYSTAR HOLDING CORP (WAY). This can be considered as Fairly Valued.
Can you provide the profitability details for WAYSTAR HOLDING CORP?
WAYSTAR HOLDING CORP (WAY) has a profitability rating of 6 / 10.
How financially healthy is WAYSTAR HOLDING CORP?
The financial health rating of WAYSTAR HOLDING CORP (WAY) is 4 / 10.
What is the expected EPS growth for WAYSTAR HOLDING CORP (WAY) stock?
The Earnings per Share (EPS) of WAYSTAR HOLDING CORP (WAY) is expected to grow by 17.16% in the next year.